Doctor profile · Federal record

Dr. Mary-Esther Gurney, PA-C

Physician Assistant · Student in an Organized Health Care Education/Training Program · Dallas, TX

  • NPI 1487823043
  • Accepts Medicare
  • MIPS 81.3 / 100 · 2023
  • 19 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
12221 Merit Dr, Ste 1610
Dallas, TX 752512202
(214) 217-1911
fax (214) 217-1912

Credentials & registration

NPPES · NUCC
NPI registered
February 2008 — 18 yrs on file
Profile last updated
October 23, 2012
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Texas #PA05654
Medicaid (3)
TX #281765201 · TX #281765203 · TX #281765202

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1487823043. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,132
Distinct HCPCS
10
Medicare allowed
$111,393
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 718 109 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 313 205 $74
17000 Destruction of precancer skin growth, 1 growth 237 150 $39
17110 Destruction of skin growth, 1-14 growths 216 147 $92
11102 Biopsy of related skin growth, first growth 166 124 $68
99212 Established patient office or other outpatient visit, 10-19 minutes 121 85 $47
11103 Biopsy of related skin growth, each additional growth 72 49 $42
99214 Established patient office or other outpatient visit, 30-39 minutes 71 53 $106
99203 New patient office or other outpatient visit, 30-44 minutes 52 52 $93
17004 Destruction of precancer skin growth, 15 or more growths 43 26 $140

In context: peer comparison

Among 190 peers in this city , average services per provider: 90. This provider delivers 24× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,018
Transactions
63
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 12 $245.48
ABBVIE INC. 11 $163.72
Arcutis Biotherapeutics, Inc. 14 $133.16
E.R. Squibb & Sons, L.L.C. 5 $94.34
UCB, Inc. 3 $73.39
MAYNE PHARMA COMMERCIAL LLC 7 $69.76
Janssen Biotech, Inc. 1 $47.99
Regeneron Healthcare Solutions, Inc. 2 $47.70
PFIZER INC. 2 $42.37
Incyte Corporation 2 $39.73
Fidia Pharma USA Inc. 1 $16.51
Dermavant Sciences, Inc. 1 $16.15
Galderma Laboratories, L.P. 1 $14.77
SUN PHARMACEUTICAL INDUSTRIES INC. 1 $13.31

By nature of payment

Food and Beverage
$970
Education
$48

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
376
Patients
235
Total drug cost
$9,054
Drug Type Claims Patients Total cost
Ketoconazole Generic 105 64 $2,551
Triamcinolone Acetonide Generic 74 67 $712
Clobetasol Propionate Generic 36 28 $1,416
Minocycline Hcl Generic 29 21 $438
Hydrocortisone Generic 23 18 $120
Clindamycin Phosphate Generic 19 12 $858
Doxycycline Monohydrate Generic 18 12 $360
Mupirocin Generic 18 13 $173
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 16 0 $269
Terbinafine Hcl Generic 15 0 $105

Frequently asked questions

Auto-generated from federal data
What is Dr. Mary-Esther Gurney's medical specialty?
Dr. Mary-Esther Gurney practices Physician Assistant in Dallas, TX.
Where does Dr. Mary-Esther Gurney practice?
Dr. Mary-Esther Gurney practices at 12221 Merit Dr, Dallas, TX 752512202. Office phone: 2142171911.
What is Dr. Mary-Esther Gurney's NPI?
Dr. Mary-Esther Gurney's National Provider Identifier (NPI) is 1487823043, issued by NPPES.
Does Dr. Mary-Esther Gurney accept Medicare assignment?
Yes. Dr. Mary-Esther Gurney accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary-Esther Gurney commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.